# PIPERACILLIN AND TAZOBACTAM
> **ANDA217409** · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2023-10-12
## Drug
- **FDA Application Number:** ANDA217409
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PIPERACILLIN AND TAZOBACTAM
- **Generic name:** PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM
- **Active ingredients:** PIPERACILLIN,TAZOBACTAM
- **Dosage form:** INJECTION
- **Route:** POWDER,FOR SOLUTION
- **Marketing status:** Prescription
- **Sponsor:** EUGIA PHARMA
- **Manufacturer:** Eugia US LLC
- **First approval:** 2023-10-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217409)
---
*AI Analytics · CC0 1.0*